Malaria Alert: Increased Cases Reported in Mayotte

Malaria in Mayotte – CDC Travel Alert

Alert Level: 2 (Exercise Increased Caution)

Situation Overview

Mayotte, a French overseas department in the Indian Ocean between Madagascar and Mozambique, is currently experiencing increased malaria transmission. The CDC has issued a Level 2 alert advising travelers to exercise increased caution and implement appropriate preventive measures.

Malaria is transmitted through the bite of infected Anopheles mosquitoes, typically during dawn and dusk hours. Cases have been reported in local communities, indicating active transmission in the region.

Travel Considerations

Before Travel:

  • Consult with a travel medicine clinic or healthcare provider 4–6 weeks prior to departure
  • Discuss personal risk factors, itinerary specifics, and medical history
  • Verify current malaria species and drug-resistance patterns in Mayotte
  • Ensure routine vaccinations are current

During Travel:

  • Use EPA-registered insect repellents (containing DEET, picaridin, IR3535, oil of lemon eucalyptus, para-menthane-diol, or 2-undecanone)
  • Wear long sleeves, pants, and socks, particularly during dusk and nighttime
  • Sleep in air-conditioned rooms or under insecticide-treated bed nets
  • Consider permethrin-treated clothing for high-risk areas

Post-Travel:

  • Monitor for symptoms (fever, chills, headache, muscle aches) for up to one year
  • Seek immediate medical evaluation if symptoms develop
  • Inform healthcare providers of travel history to Mayotte

Key Public Health Information

  • Malaria risk varies by region and season; consult current CDC or WHO guidelines for specific areas within Mayotte
  • Antimalarial prophylaxis may be recommended depending on travel duration, destination, and personal health status
  • Malaria is preventable and treatable when diagnosed early
  • No malaria vaccine is currently available; prevention relies on mosquito avoidance and chemoprophylaxis

Pharmacist's Note: As a licensed pharmacist, I emphasize that antimalarial medications are prescription-only and require individualized assessment. Drug selection depends on local resistance patterns, personal tolerability, contraindications, and drug interactions. Common options include atovaquone-proguanil, doxycycline, and mefloquine, each with distinct profiles. Travelers must obtain prescriptions from qualified healthcare providers and complete the full course as directed—adherence is critical for efficacy. Over-the-counter "natural" alternatives lack evidence and are not recommended by public health authorities.

Resources

Primary sources

PharmTrip may include promotional content. Products and services are independently evaluated by a licensed pharmacist and rankings are never altered by advertiser requests. Information reflects what was current at the time of writing — please verify the latest terms on each provider's official site.